The c-erbB-2 protein product, p185, is expressed in 20–30% of non-small-cell lung cancers (NSCLC) and particularly in adenocarcinoma (Tateishi et al, 1991; Kern et al, 1994). This evidence concerns the gene EIF3A and non-small cell lung carcinoma.